SS

Sreehari Sudarsana Kumar Rathika Devi

Active Director Director DIN 08820656
DIN 08820656 First appointment Aug 2020 Primary industry Food And Beverages
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Sreehari Sudarsana Kumar Rathika Devi

Data last updated:

Sreehari Sudarsana Kumar Rathika Devi is a Director at Glaxin Pharmaceuticals Private Limited (since 2020). The company operates in Food And Beverages.

DIN 08820656
Primary Designation Director
Industry Food And Beverages
First Appointment 03 Aug 2020
Oldest Company Age 7 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Aug 20202019Active

Board colleagues of Sreehari Sudarsana Kumar Rathika Devi

Directorship timeline

Open interactive timeline →
Glaxin Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sreehari Sudarsana Kumar Rathika Devi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sreehari Sudarsana Kumar Rathika Devi

Sreehari Sudarsana Kumar Rathika Devi currently holds 1 directorship: Glaxin Pharmaceuticals Private Limited (Director, since 03 Aug 2020).

Sreehari Sudarsana Kumar Rathika Devi was first appointed on 03 Aug 2020 as Director at Glaxin Pharmaceuticals Private Limited.

The current boards of Sreehari Sudarsana Kumar Rathika Devi's companies include Santhoshkumari Santhamma (Glaxin Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available